GW Henssler & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
GW Henssler & Associates's PFE Position: Q1 2026 in Review
GW Henssler & Associates increased its Pfizer (PFE) stake by 51% in Q1 2026, buying an estimated $117K and bringing the position to 13,050 shares worth $366K. The position accounts for 0.02% of the portfolio, ranked #155.
GW Henssler & Associates first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $12.6M in Q2 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- GW Henssler & Associates held 13,050 shares of Pfizer worth $366K as of Q1 2026.
- GW Henssler & Associates bought 4,400 Pfizer shares in Q1 2026, an estimated $117K.
- Pfizer made up 0.02% of GW Henssler & Associates's portfolio in Q1 2026, its #155 holding.
- GW Henssler & Associates first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
- GW Henssler & Associates's Pfizer position peaked at $12.6M in Q2 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on GW Henssler & Associates's 13F filing for Q1 2026, filed 15 May 2026.